Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tsunefusa Hayashida

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Global Health & Medicine|November 1, 2024
Identification of new circulating recombinant form of HIV-1 CRF139_02B in Japan, and search for the originTsunefusa Hayashida, Kiyoto Tsuchiya, Shinichi Oka, et al.
AIDS Research and Human Retroviruses|March 11, 2008
Effects of low HIV type 1 load and antiretroviral treatment on IgG-capture BED-enzyme immunoassayTsunefusa Hayashida, Hiroyuki Gatanaga, Junko Tanuma, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 15, 2013
Prophylactic effect of antiretroviral therapy on hepatitis B virus infectionHiroyuki Gatanaga, Tsunefusa Hayashida, Junko Tanuma, et al.
Plos One|May 5, 2017
Emergence of CXCR4-tropic HIV-1 variants followed by rapid disease progression in hemophiliac slow progressorsTsunefusa Hayashida, Kiyoto Tsuchiya, Yoshimi Kikuchi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 21, 2016
Brief Report: High Peak Level of Plasma Raltegravir Concentration in Patients With ABCB1 and ABCG2 Genetic VariantsKiyoto Tsuchiya, Tsunefusa Hayashida, Akinobu Hamada, et al.
Pharmacogenetics and Genomics|September 1, 2017
High plasma concentrations of dolutegravir in patients with ABCG2 genetic variantsKiyoto Tsuchiya, Tsunefusa Hayashida, Akinobu Hamada, et al.
Antimicrobial Agents and Chemotherapy|February 4, 2010
Combination of V106I and V179D polymorphic mutations in human immunodeficiency virus type 1 reverse transcriptase confers resistance to efavirenz and nevirapine but not etravirineHiroyuki Gatanaga, Hirotaka Ode, Atsuko Hachiya, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 8, 2009
Allele and genotype frequencies of cytochrome P450 2B6 gene in a Mongolian populationJagdagsuren Davaalkham, Tsunefusa Hayashida, Kiyoto Tsuchiya, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 30, 2014
Low raltegravir concentration in cerebrospinal fluid in patients with ABCG2 genetic variantsKiyoto Tsuchiya, Tsunefusa Hayashida, Akinobu Hamada, et al.
Plos One|November 5, 2015
Drug Transporter Genetic Variants Are Not Associated with TDF-Related Renal Dysfunction in Patients with HIV-1 Infection: A Pharmacogenetic StudyTakeshi Nishijima, Tsunefusa Hayashida, Takuma Kurosawa, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Global Health & Medicine|November 1, 2024
Identification of new circulating recombinant form of HIV-1 CRF139_02B in Japan, and search for the originTsunefusa Hayashida, Kiyoto Tsuchiya, Shinichi Oka, et al.
AIDS Research and Human Retroviruses|March 11, 2008
Effects of low HIV type 1 load and antiretroviral treatment on IgG-capture BED-enzyme immunoassayTsunefusa Hayashida, Hiroyuki Gatanaga, Junko Tanuma, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 15, 2013
Prophylactic effect of antiretroviral therapy on hepatitis B virus infectionHiroyuki Gatanaga, Tsunefusa Hayashida, Junko Tanuma, et al.
Plos One|May 5, 2017
Emergence of CXCR4-tropic HIV-1 variants followed by rapid disease progression in hemophiliac slow progressorsTsunefusa Hayashida, Kiyoto Tsuchiya, Yoshimi Kikuchi, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|April 21, 2016
Brief Report: High Peak Level of Plasma Raltegravir Concentration in Patients With ABCB1 and ABCG2 Genetic VariantsKiyoto Tsuchiya, Tsunefusa Hayashida, Akinobu Hamada, et al.
Pharmacogenetics and Genomics|September 1, 2017
High plasma concentrations of dolutegravir in patients with ABCG2 genetic variantsKiyoto Tsuchiya, Tsunefusa Hayashida, Akinobu Hamada, et al.
Antimicrobial Agents and Chemotherapy|February 4, 2010
Combination of V106I and V179D polymorphic mutations in human immunodeficiency virus type 1 reverse transcriptase confers resistance to efavirenz and nevirapine but not etravirineHiroyuki Gatanaga, Hirotaka Ode, Atsuko Hachiya, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 8, 2009
Allele and genotype frequencies of cytochrome P450 2B6 gene in a Mongolian populationJagdagsuren Davaalkham, Tsunefusa Hayashida, Kiyoto Tsuchiya, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 30, 2014
Low raltegravir concentration in cerebrospinal fluid in patients with ABCG2 genetic variantsKiyoto Tsuchiya, Tsunefusa Hayashida, Akinobu Hamada, et al.
Plos One|November 5, 2015
Drug Transporter Genetic Variants Are Not Associated with TDF-Related Renal Dysfunction in Patients with HIV-1 Infection: A Pharmacogenetic StudyTakeshi Nishijima, Tsunefusa Hayashida, Takuma Kurosawa, et al.
Pageof 4